GAIN THERAPEUTIC (GANX): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in GANX · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
4
13F filers
Aggregate Value
$6.4M
Across holders
Last Price
$1.61
2026-10-08
Sector
Health Care
GICS
Quarterly fund activity3 increased0 reduced1 exited
Full exits: Schonfeld Strategic Advisors LLC
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 1.92M | $3.9M | 60.9% | 0.0% | Added | $-2.1M | Q2 2026 |
| GREENLIGHT CAPITAL INC CIK 0001079114 | Hedge Fund | 588K | $1.9M | 29.9% | 0.1% | Unchanged | +$1.2M | Q4 2023 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 155K | $314K | 4.9% | 0.0% | Added | +$250K | Q2 2026 |
| Squarepoint Ops LLC CIK 0001642575 | Hedge Fund | 136K | $277K | 4.3% | 0.0% | Added | — | Q2 2026 |
Added
Hedge Fund
$3.9M· 60.9% of total· 0.0% port· 1.92M sh· $-2.1M QoQ· Q2 2026
Unchanged
Hedge Fund
$1.9M· 29.9% of total· 0.1% port· 588K sh· +$1.2M QoQ· Q4 2023
Added
Hedge Fund
$314K· 4.9% of total· 0.0% port· 155K sh· +$250K QoQ· Q2 2026
Added
Hedge Fund
$277K· 4.3% of total· 0.0% port· 136K sh· — QoQ· Q2 2026
Loading recent insider activity…